26th Jul 2018 13:05
LONDON (Alliance News) - Shield Therapeutics PLC, a commercial stage pharmaceutical company, said Thursday that it has appointed Hans-Peter Hasler as non-executive director with immediate effect.
Hasler is the founder and chief executive of Vicarius Pharma and an advisor to SBTech Global Advisory.
"On behalf of the board, I'd like to welcome Hans-Peter to Shield and trust his broad experience of commercial operations and negotiations in pharmaceutical transactions will be a great asset to the company in the coming months and beyond," said Shield Therapeutics CEO Carl Sterritt.
Shares in Shield Therapeutics were untraded at 38.50 pence each on Thursday.
Related Shares:
Shield Thera